United States · Series C startup
3 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$82Mraised across 3 rounds since 2012, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Cormorant Asset Management
F-Prime Capital
Sofinnova Investments
Vivo Capital
Rock Springs CapitalFrom a historical funding recordSEC filing: $40M sold, first sale Aug 2015
From a historical funding recordSEC filing: $11M sold, first sale Sept 2014
Reported by finsmes.comSEC filing: $21M sold, first sale Aug 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
F-Prime CapitalSofinnova Investments
Vivo VenturesFidelity BiosciencesRA Capital ManagementCormorant Asset ManagementVivo CapitalRock Springs CapitalAperture Venture PartnersAclaris TherapeuticsMissing a round, or an investor who was in one? Tell us.
Aclaris Therapeutics's investors include F-Prime Capital, Sofinnova Investments, Vivo Ventures, Fidelity Biosciences and RA Capital Management, and 6 more on record.
Aclaris Therapeutics has raised $82M across 3 rounds since 2012.
Aclaris Therapeutics's most recent round was a Series C of $40M in Sept 2015.
Its most recent round, $40M in Sept 2015, is also its largest on record.
Aclaris Therapeutics's first round on record, in Oct 2012, was backed by F-Prime Capital, Sofinnova Investments and Vivo Ventures and 1 others.
Aclaris Therapeutics's latest named round is a Series C, in Sept 2015.
Aclaris Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·